Lacerta Therapeutics, Inc. announced it raised $500,000 in an initial filing from an offering of $500,000

Aug 07, 2018•over 7 years ago

Amount Raised

$500,000

Round Type

seed

AlachuaBiotechnology

Company Information

Company

Lacerta Therapeutics, Inc.

Location

12085 RESEARCH DRIVE

Alachua, Florida, United States

About

Lacerta Therapeutics is a clinical stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies.

6 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech